Letrozole, a new oral non-steroidal aromastase inhibitor in treating postmenopausal patients with advanced breast cancer. A pilot study

Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in postmenopausal patients with advanced breast cancer.

Timothy Iveson, I E Smith, Julie Ahern et al. · PubMed · 1993 · 130 citations

Medicine, Oncology, Pharmacology +16

Letrozole (CGS 20267). A phase I study of a new potent oral aromatase inhibitor of breast cancer

A Lipton, Laurence M. Demers, Harold A. Harvey et al. · Cancer · 1995 · 113 citations

Medicine, Oncology, Pharmacology +17

Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in healthy postmenopausal women.

Timothy Iveson, Ian E. Smith, Julie Ahern et al. · The Journal of Clinical Endocrinology & Metabolism · 1993 · 80 citations

Medicine, Endocrinology, Pharmacology +17

Open dose-finding study of a new potent and selective nonsteroidal aromatase inhibitor, CGS 20 267, in healthy male subjects.

P Trunet, Paul S. Mueller, A.S. Bhatnagar et al. · The Journal of Clinical Endocrinology & Metabolism · 1993 · 69 citations

Life Sciences, Endocrinology, Pharmacology +17

The effects of fadrozole hydrochloride on aldosterone secretion in healthy male subjects.

P Trunet, Paul S. Mueller, F Girard et al. · The Journal of Clinical Endocrinology & Metabolism · 1992 · 45 citations

Medicine, Endocrinology, Pharmacology +17